BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Express Healthcare - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.expresshealthcare.in
X-WR-CALDESC:Events for Express Healthcare
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20190101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Asia/Kolkata:20200929T140000
DTEND;TZID=Asia/Kolkata:20200929T150000
DTSTAMP:20260425T073659
CREATED:20200916T102449Z
LAST-MODIFIED:20200928T044858Z
UID:424766-1601388000-1601391600@www.expresshealthcare.in
SUMMARY:Value of NT-proBNP and Troponin in diagnosis & therapy management of heart failure patients | 29th September 2020
DESCRIPTION:Register Now \n\nWorld Heart Day is celebrated every year on 29th September. \nCardiovascular Disorders (CVD)\, including heart disease and stroke\, is the world’s leading cause of death claiming 17.9 million lives each year. Beginning of 2020\, brought with itself the unheard novel corona virus with potentially severe consequences. Many trends emerged over the course of time and one such is that COVID-19 posed a particular risk to patients with underlying issues such as heart disease\, which is already the leading cause of death in the planet. \nDiagnosing heart failure (HF) in patients presenting in the Emergency Department (ED) is difficult. Clinical assessment of symptoms and signs has limited sensitivity and specificity. Often\, patients are elderly with comorbidity\, symptoms may be mild\, and echocardiography may not be universally available. In such circumstances\, cardiac biomarkers viz.\, NT-proBNP and Troponin tests in the ED aids in the correct identification and selecting the patient who need an echocardiographic study. In addition\, it results in an optimization of healthcare resources for patients at risk of adverse events allowing for intensified care. \n1. https://www.world-heart-federation.org/world-heart-day/about-whd/\n2. https://acutecaretesting.org/en/articles/nt-probnp-for-heart-failure-diagnosis-in-primary-care \nTake the opportunity to learn from the expert panelists: \n\nWhat is the trend in diagnosis of acute heart failure\nHow can the natriuretic peptide NT-proBNP or BNP help in the diagnosis in dyspneic patients presented the ED\nCan it lower the diagnosis uncertainty and lower the rate of unnecessary imaging\nHow can the natriuretic peptide\, NT-proBNP or BNP be used for risk stratification\nWhat is the trend in therapy management of acute heart failure\nIn therapy management of sacubitril/valsartan\, can the natriuretic peptides – BNP and NT-proBNP be used with patients undergoing therapy\nWhy is NT-proBNP more suitable to use\n\nWho should attend? \n\nCardiologists\nCritical Care Specialists\nEmergency Physicians\n\nExpert Panelists: \n\nDr. Sandeep Gore\, Director\, Emergency Medicine\, Fortis Hospital\, Mulund\, Mumbai\nDr. (Col) Suvasish Chakraberty\, Director\, Emergency & Trauma Services\, Artemis Hospital\, Gurugram\nDr. Kiron Verghese\, Professor and Head\, Department Of Cardiology\, Chief Interventional Cardiologist\, St John’s Medical College\, Bangalore\n\nDr. Sanjukta Dutta\, Consultant and Head\, Emergency Medicine Department\, Fortis Hospital\, Kolkata
URL:https://www.expresshealthcare.in/event/value-of-nt-probnp-and-troponin-in-diagnosis-therapy-management-of-heart-failure-patients-29th-september-2020/
LOCATION:Live Webinar
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/jpeg:https://cdn.expresshealthcare.in/wp-content/uploads/2020/09/22153137/EH_Radiometer_290920_EvPg_LivePD.jpg
END:VEVENT
END:VCALENDAR